SPX-101 structure
|
Common Name | SPX-101 | ||
|---|---|---|---|---|
| CAS Number | 2219362-20-4 | Molecular Weight | 1179.385 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C53H90N14O16 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of SPX-101SPX-101 is a specific, peptide mimetic promoter of epithelial sodium channel (ENaC) internalization, binds selectively to ENaC and promotes internalization of the α-, β-, and γ-subunits; promotes durable reduction of ENaC membrane concentration, increases mucus transport in the β-ENaC mouse model as well as the sheep model of CF. Fibrosis Phase 2 Clinical |
| Name | SPX-101 |
|---|
| Description | SPX-101 is a specific, peptide mimetic promoter of epithelial sodium channel (ENaC) internalization, binds selectively to ENaC and promotes internalization of the α-, β-, and γ-subunits; promotes durable reduction of ENaC membrane concentration, increases mucus transport in the β-ENaC mouse model as well as the sheep model of CF. Fibrosis Phase 2 Clinical |
|---|---|
| References | References 1. Scott DW, et al. Am J Respir Crit Care Med. 2017 Sep 15;196(6):734-744. 2. Lennox A, et al. Am J Respir Crit Care Med. 2017 Sep 15;196(6):671-672. View Related Products by Target Sodium Channel Fibrosis |
| Molecular Formula | C53H90N14O16 |
|---|---|
| Molecular Weight | 1179.385 |
| InChIKey | GHHZWRGZMXHMIQ-DZLDEHGNSA-N |
| SMILES | CCC(C)C(NC(=O)C1CCCN1C(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(C)N)C(=O)N1CCCC1C(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(C)C(=O)NC(C)C(N)=O)C(C)O |